Search

Your search keyword '"Aastha Agarwal"' showing total 17 results
Start Over Author "Aastha Agarwal" Language undetermined
17 results on '"Aastha Agarwal"'

1. Relapsing donovanosis rhyming with unexplained decline in CD4 count in a person living with HIV/AIDS: Long-term follow up and therapeutic outcome

Author

Surabhi Sinha, Kabir Sardana, Aastha Agarwal, and Arvind Ahuja

Subjects
Infectious Diseases, Public Health, Environmental and Occupational Health, Pharmacology (medical), Dermatology
Abstract

Donovanosis is a chronic genital ulcerative disease caused by the intracellular Gram-negative bacterium Klebsiella granulomatis, reported more frequently in people living with HIV/AIDS (PLHA). Here we present a case of relapsing donovanosis in a PLHA on second line antiretroviral therapy who had episodes of transient unexplained decrease in CD4 counts associated with rapid growth of the lesion and non-responsiveness to treatment followed by clinical resolution coinciding with recovery of the CD4 count.

Published
2023

2. Privacy Protection Framework for Android

Author

Bharavi Mishra, Aastha Agarwal, Ayush Goel, Aman Ahmad Ansari, Pramod Gaur, Dilbag Singh, and Heung-No Lee

Subjects
instrumentation, General Computer Science, Android, General Engineering, General Materials Science, security, Electrical engineering. Electronics. Nuclear engineering, permission model, privacy, TK1-9971
Abstract

The increase in popularity and users of the Android platform in recent years has led to a lot of innovative and smart Android applications (apps). Many of these apps are highly interactive, customizable, and require user data to provide services. While being convenient, user privacy is the primary concern. It is not guaranteed that these apps are not storing user data for their need or scrapping algorithms through them. Android uses the system of permissions to provide security and protect user data. The user can grant permission for requested resources either at runtime or during the installation process. However, this system is often misused in practice by demanding extra permissions that are not required to provide services. These kinds of apps stop functioning if all permissions are not granted to them. Therefore, in this paper, a privacy preserved secure framework is proposed to prevent an app from stealing user data by restricting all unnecessary permissions. Unnecessary permissions are recognized by predicting the permissions required by a given app by using collaborative filtering and frequent permission set mining algorithms. Thus, the proposed model interacts with the target application and modifies the permission data inside. Experimental results reveal that the proposed model not only protects the user data but also ensures the proper functioning of the given application.

Published
2022

3. Contributors

Author

Mark J. Abzug, Elisabeth E. Adderson, Aastha Agarwal, Allison L. Agwu, Lindsey Albenberg, Jonathan Albert, Kevin Alby, Grace M. Aldrovandi, Upton D. Allen, Gerardo Alvarez-Hernndez, Krow Ampofo, Evan J. Anderson, Grace D. Appiah, Monica I. Ardura, Stephen S. Arnon, Naomi E. Aronson, Ann M. Arvin, Shai Ashkenazi, Liat Ashkenazi-Hoffnung, Edwin J. Asturias, Kestutis Aukstuolis, Vahe Badalyan, Carol J. Baker, Karthik Balakrishnan, Elizabeth D. Barnett, Kirsten Bechtel, William E. Benitz, Rachel Berkovich, David M. Berman, Stephanie R. Bialek, Else M. Bijker, Matthew J. Bizzarro, Karen C. Bloch, Joseph A. Bocchini, Thomas G. Boyce, John S. Bradley, Denise F. Bratcher, Paula K. Braverman, Itzhak Brook, Kevin Edward Brown, Kristina P. Bryant, Andres F. Camacho-Gonzalez, Connie F. Caete-Gibas, Joseph B. Cantey, Paul Cantey, Cristina V. Cardemil, Mary T. Caserta, Luis A. Castagnini, Jessica R. Cataldi, Ellen Gould Chadwick, Rebecca J. Chancey, Cara C. Cherry, Silvia S. Chiang, Mary Choi, John C. Christenson, Susan E. Coffin, Amanda Cohn, Despina G. Contopoulos-Ioannidis, James H. Conway, Margaret M. Cortese, C. Buddy Creech, Jonathan D. Crews, Donna Curtis, Nigel Curtis, Lara A. Danziger-Isakov, Toni Darville, Gregory A. Dasch, Irini Daskalaki, H. Dele Davies, Fatimah S. Dawood, J. Christopher Day, M. Teresa de la Morena, Gregory P. DeMuri, Dickson D. Despommier, Daniel S. Dodson, Stephen J. Dolgner, Clinton Dunn, Jonathan Dyal, Kathryn M. Edwards, Morven S. Edwards, Dawn Z. Eichenfield, Lawrence F. Eichenfield, Dirk M. Elston, Beth Emerson, Leslie A. Enane, Moshe Ephros, Guliz Erdem, Marina E. Eremeeva, Douglas H. Esposito, Monica M. Farley, Anat R. Feingold, Kristina N. Feja, Adam Finn, Marc Fischer, Brian T. Fisher, Randall G. Fisher, Patricia Michele Flynn, Monique A. Foster, LeAnne M. Fox, Michael M. Frank, Douglas R. Fredrick, Robert W. Frenck, James Gaensbauer, Hayley A. Gans, Gregory M. Gauthier, Patrick Gavigan, Jeffrey S. Gerber, Yael Gernez, Francis Gigliotti, Mark A. Gilger, Carol A. Glaser, Jane M. Gould, James Graziano, Amanda M. Green, Michael Green, Daniel Griffin, Patricia M. Griffin, David C. Griffith, Piyush Gupta, Bruce J. Gutelius, Julie R. Gutman, Aron J. Hall, Rana F. Hamdy, Jin-Young Han, Lori K. Handy, Benjamin Hanisch, Marvin B. Harper, Aaron M. Harris, Christopher J. Harrison, David B. Haslam, Julia C. Haston, Sarah.J. Hawkes, Taylor Heald-Sargent, J. Owen Hendley, Adam L. Hersh, Joseph A. Hilinski, Susan L. Hills, David K. Hong, Peter J. Hotez, Katherine K. Hsu, Felicia Scaggs Huang, David A. Hunstad, W. Garrett Hunt, Loris Y. Hwang, Christelle M. Ilboudo, Preeti Jaggi, Sophonie Jean, Ravi Jhaveri, Kateina Jirk-Pomajbkov, Nadia A. Kadry, Mary L. Kamb, Ronak K. Kapadia, Ben Z. Katz, Sophie E. Katz, Ishminder Kaur, Gilbert J. Kersh, Muhammad Ali Khan, Ananta Khurana, David W. Kimberlin, Bruce Klein, Miwako Kobayashi, Larry K. Kociolek, Andrew Y. Koh, Karen L. Kotloff, Andrew T. Kroger, Matthew P. Kronman, Leah Lalor, Christine T. Lauren, Amy Leber, Eyal Leshem, David B. Lewis, Robyn A. Livingston, Eloisa Llata, Kevin Lloyd, Katrina Loh, Sarah S. Long, Benjamin A. Lopman, Yalda C. Lucero, Debra J. Lugo, Jorge Lujn-Zilbermann, Yvonne A. Maldonado, John J. Manaloor, Kalpana Manthiram, Stacey W. Martin, Roshni Mathew, Tony Mazzulli, Elizabeth J. McFarland, Kathleen A. McGann, Lucy A. McNamara, Debrah Meislich, H. Cody Meissner, Asuncion Mejias, Jussi Mertsola, Kevin Messacar, Mohammad Nael Mhaissen, Marian G. Michaels, Melissa B. Miller, Hilary Miller-Handley, Eric Mintz, Parvathi Mohan, Susan P. Montgomery, Jose G. Montoya, Anne C. Moorman, Pedro L. Moro, Anna-Barbara Moscicki, William J. Muller, Angela L. Myers, Simon Nadel, Jennifer Lynn Nayak, Michael Noel Neely, Karen P. Neil, Christina A. Nelson, Noele P. Nelson, Megin Nichols, William Nicholson, Amy Jo Nopper, Laura E. Norton, Theresa J. Ochoa, Liset Olarte, Timothy R. Onarecker, Walter A. Orenstein, Miguel ORyan, William R. Otto, Christopher P. Ouellette, Christopher D. Paddock, Debra L. Palazzi, Suresh Kumar Panuganti, Diane E. Pappas, Michal Paret, Daniel M. Pastula, Thomas F. Patterson, Brett W. Petersen, Mikael Petrosyan, Larry K. Pickering, Talia Pindyck, Swetha Pinninti, Laure F. Pittet, Paul J. Planet, Andrew J. Pollard, Klara M. Posfay-Barbe, Casper S. Poulsen, Susan M. Poutanen, Ann M. Powers, Nina Salinger Prasanphanich, Bobbi S. Pritt, Charles G. Prober, Neha Puar, Laura A.S. Quilter, Octavio Ramilo, Suchitra Rao, Adam J. Ratner, Sarah A. Rawstron, Jennifer S. Read, Ryan F. Relich, Megan E. Reller, Candice L. Robinson, Jos R. Romero, David A. Rosen, Shannon A. Ross, G. Ingrid J.G. Rours, Peter C. Rowe, Anne H. Rowley, Lorry G. Rubin, Edward T. Ryan, Alexandra Sacharok, Thomas J. Sandora, Sarah G.H. Sapp, Kabir Sardana, Jason B. Sauberan, Joshua K. Schaffzin, Sarah Schillie, Jennifer E. Schuster, Kevin L. Schwartz, Bethany K. Sederdahl, Jose Serpa-Alvarez, Kara N. Shah, Samir S. Shah, Nader Shaikh, Andi L. Shane, Eugene D. Shapiro, Jana Shaw, Avinash K. Shetty, Timothy R. Shope, Linda M. Dairiki Shortliffe, Stanford T. Shulman, Gail F. Shust, George Kelly Siberry, Jane D. Siegel, Robert David Siegel, Kari A. Simonsen, Upinder Singh, Christiana Smith, Lauren L. Smith, Eunkyung Song, Emily Souder, Paul Spearman, Joseph W. St. Geme, Mary Allen Staat, J. Erin Staples, Jeffrey R. Starke, Victoria A. Statler, William J. Steinbach, Christen Rune Stensvold, Erin K. Stokes, Bradley P. Stoner, Gregory A. Storch, Anne Straily, Kathleen E. Sullivan, Douglas S. Swanson, Robert R. Tanz, Gillian Taormina, Jacqueline E. Tate, Jeanette Taveras, Marc Tebruegge, Eyasu H. Teshale, George R. Thompson, Robert Thompson-Stone, Isaac Thomsen, Richard B. Thomson, Emily A. Thorell, Vivian Tien, Nicole H. Tobin, Philip Toltzis, James Treat, Stephanie B. Troy, Russell B. Van Dvke, Louise Elaine Vaz, Vini Vijayan, Jennifer Vodzak, Thor A. Wagner, Ellen R. Wald, Rebecca Wallihan, Huanyu Wang, Zoon Wangu, Matthew Washam, Valerie Waters, Joshua R. Watson, Jill E. Weatherhead, Geoffrey A. Weinberg, Mark K. Weng, Nathan P. Wiederhold, Harold C. Wiesenfeld, Cydni Williams, John V. Williams, Rodney E. Willoughby, Robert R. Wittler, James B. Wood, Charles Reece Woods, Kimberly A. Workowski, Terry W. Wright, Hsi-Yang Wu, Huan Xu, Pablo Yagupsky, Jumi Yi, Jonathan Yoder, Edward J. Young, Andrea L. Zaenglein, Petra Zimmermann, and Wenjing Zong

Published
2023

7. Repurposing super saturated potassium iodide as an adjunctive treatment in mucormycosis: An exposition in a diabetic patient with rhino‐orbital disease with cutaneous extension

Author

Purnima Malhotra, Pooja Arora, Ankur Majumder, Aastha Agarwal, Kabir Sardana, Ankur Gupta, and Sachin Goel

Subjects
medicine.medical_specialty, Antifungal Agents, business.industry, Mucormycosis, Potassium Iodide, chemistry.chemical_element, Dermatology, General Medicine, Iodine, medicine.disease, Orbital disease, chemistry, Adjunctive treatment, Diabetes Mellitus, Orbital Diseases, Humans, Medicine, Diabetic patient, business, Repurposing
Published
2021

10. Effect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris

Author

Ananta, Khurana, Aastha, Agarwal, Diksha, Agrawal, Sanjeet, Panesar, Manik, Ghadlinge, Kabir, Sardana, Khushboo, Sethia, Shalini, Malhotra, Ankit, Chauhan, and Nirmala, Mehta

Subjects
Dermatology
Abstract

ImportanceWith worldwide emergence of recalcitrant and resistant dermatophytosis, itraconazole is increasingly being used as the first-line drug for treatment of tinea corporis/cruris (TCC). Apparent inadequacy with low doses has led to empirical use of higher doses and antifungal combinations.ObjectiveTo compare cure rates, treatment durations, safety profiles, and relapse rates of itraconazole 100, 200, and 400 mg/d for the treatment of TCC.Design, Setting, and ParticipantsThis double-blind randomized clinical trial included adult patients with treatment-naive TCC involving at least 5% body surface area. Patients were recruited from the dermatology outpatient department of a tertiary care hospital in New Delhi, India between March 1, 2020, and August 31, 2021.InterventionsPatients were randomized to 1 of the 3 treatment groups. Biweekly blinded assessments were performed until cure or treatment failure. Posttreatment follow-up of at least 8 weeks was conducted to detect relapses.Main Outcome and MeasuresCure rates, treatment durations, safety profiles, and relapse rates were assessed. Secondary outcomes included comparison of rapidity of clinical response and cost-effectiveness between groups.ResultsOf the 149 patients assessed, the mean (SD) age was 34.3 (12.2) years, 69 patients (46.4%) were women, and 80 patients (53.6%) were men. The difference in cure rate between the 100- and 200-mg groups was statistically nonsignificant (hazard ratio [HR], 1.44; 95% CI, 0.91-2.30; P = .12), while the difference between the 100- and 400-mg groups (HR, 2.87; 95% CI, 1.78-4.62; P P = .002) was statistically significant. Mean (SD) treatment durations were statistically significantly different between the 100- and 400-mg groups (7.7 [4.7] weeks vs 5.2 [2.6] weeks; P = .03) and between the 200- and 400-mg groups (7.2 [3.8] weeks vs 5.2 [2.6] weeks; P = .004), but the difference between the 100- and 200-mg groups was not statistically significant. A total of 55 patients (47.4%) relapsed after treatment. Relapse rates were comparable across groups. No patient discontinued treatment due to adverse effects. Treatment with the 200-mg dose incurred a 63% higher cost and 400 mg a 120% higher cost over 100 mg in achieving cure.Conclusions and RelevanceIn this randomized clinical trial, high overall efficacy was observed among the 3 itraconazole doses for treatment of TCC, but with prolonged treatment durations and considerable relapse rates. Treatment with the 200- and 100-mg doses did not differ significantly in efficacy or treatment durations, while 400 mg scored over the other 2 on these outcomes. Considerable additional cost is incurred in achieving cure with the 200- and 400-mg doses.Trial RegistrationClinical Trials Registry of India Identifier: CTRI/2020/03/024326

Published
2022

13. Hydroxychloroquine-induced erythroderma: A rare adverse effect of a commonly used drug

Author

Priyadharshini Kathirvel, Aastha Agarwal, Anusha Katare, Arvind Ahuja, and Ananta Khurana

Subjects
Drug, medicine.medical_specialty, Letter, Drug-Related Side Effects and Adverse Reactions, media_common.quotation_subject, MEDLINE, Erythroderma, Dermatology, Medicine, Humans, Drug reaction, Letters, Adverse effect, media_common, business.industry, Hydroxychloroquine, General Medicine, medicine.disease, Pharmaceutical Preparations, Drug Eruptions, business, Dermatitis, Exfoliative, medicine.drug
Published
2020

14. Understanding and Practices of Gynaecologists Related to Breast Cancer Screening, Detection, Treatment and Common Breast Diseases: A Study from India

Author

Aastha Agarwal, Vinod Jain, Gitika N. Singh, and Priti Kumar

Subjects
Adult, medicine.medical_specialty, India, Breast Neoplasms, Benign breast diseases, 03 medical and health sciences, Breast cancer screening, 0302 clinical medicine, Breast cancer, Obstetrics and gynaecology, Risk Factors, Surveys and Questionnaires, medicine, Humans, Practice Patterns, Physicians', Early Detection of Cancer, Aged, medicine.diagnostic_test, business.industry, Obstetrics, Middle Aged, Vascular surgery, medicine.disease, Cross-Sectional Studies, Gynecology, Cardiothoracic surgery, 030220 oncology & carcinogenesis, Female, 030211 gastroenterology & hepatology, Surgery, Clinical Competence, business, Uttar pradesh, Abdominal surgery
Abstract

The knowledge of breast cancer risk factors and screening practices in a community is largely influenced by the practising gynaecologist in that area. We assessed the understanding and knowledge of gynaecologists about breast cancer: screening, risk factors, clinical signs, management and common benign breast diseases. This cross-sectional study was carried out in Uttar Pradesh, India, from April to September 2017. One hundred and fifty-two gynaecologists were assessed using a self-designed and validated questionnaire to assess the knowledge of risk factors, clinical signs, screening practices and management of breast cancer as well as common benign breast diseases. Further, the results were compared based on their education: undergraduates (UGs; no residency experience in obstetrics and gynaecology) versus postgraduates (PGs; residency experience in obstetrics and gynaecology). 67 and 82.2% of gynaecologists possess excellent to very good knowledge of risk factors and clinical signs of breast cancer, respectively. The knowledge of PGs seems to be better than UGs (p

Published
2018

16. 4-Input Decimal Adder Using 90 nm CMOS Technology

Author

Aastha Agarwal and Meena Aggarwal

Subjects
Adder, Computer science, business.industry, Schematic, Decimal, law.invention, Microprocessor, Application-specific integrated circuit, CMOS, law, Hardware_INTEGRATEDCIRCUITS, Netlist, Verilog, Hardware_ARITHMETICANDLOGICSTRUCTURES, business, computer, Computer hardware, Hardware_LOGICDESIGN, computer.programming_language
Abstract

The core of every microprocessor, digital signal processor (DSP), and data processing application-specific integrated circuit(ASIC) is its data path. At the hearts of data paths and addressing units are arithmetic units, such as a comparators , adders, and multipliers. In this paper, a 4-input decimal adder has been developed using 90 nm CMOS technology. The schematic of decimal adder is designed and simulated for its behavior using DSCH-3.1 The layout of simulated adder is created using Verilog based netlist file which is further simulated using Micro wind 3.1 to analyze the performance. The result shows that designed decimal adder has consumed 0.603mW power. Keywords-Adders, ALU,ASIC, Carry Look Ahead Adders, CMOS, Decimal Addition, DSP .

Published
2013

17. PUB082 Role of Isolated Flavonoid from Indigofera Tinctoria in N-Nitrosopyrrolidine Induced Biochemical Changes Related to Lung Cancer

Author

Veena Sharma and Aastha Agarwal

Subjects
0301 basic medicine, Pulmonary and Respiratory Medicine, chemistry.chemical_classification, biology, Traditional medicine, business.industry, Flavonoid, medicine.disease, biology.organism_classification, Indigofera tinctoria, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Oncology, chemistry, 030220 oncology & carcinogenesis, Botany, medicine, Lung cancer, business, N-Nitrosopyrrolidine
Published
2017

Catalog

Books, media, physical & digital resources
See catalog results